Pichia kudriavzevii-Introduction, Morphology, Pathogenicity, Lab Diagnosis, Treatment, Prevention, and Keynotes
Pichia kudriavzevii growth on HiCrome Candida Differential Agar
Introduction
Table of Contents
Pichia kudriavzevii, formerly known as Candida krusei, is a unique budding yeast that holds a dual status as both a critical industrial organism and an emerging opportunistic pathogen.
Taxonomy: It is the teleomorph (sexual state) of Candida krusei. It has also been historically known as Issatchenkia orientalis. ccurrence: It is ubiquitous in nature, found in soil, fruits, and fermented foods like chocolate and coffee. Industrial Importance: Used globally for bioethanol production due to its high tolerance to extreme heat (up to 45°C) and low pH (as low as 2.0).
Morphology
Microscopic Appearance: Produces ovoid or elongated ellipsoidal budding cells, often described as having a “match-stick” or “long-grain rice” appearance.
Fig. Pichia kudriavzevii structures in the wet mount of the germ tube test
Culture Characteristics:
Agar (SDA): Colonies are typically flat, wrinkled, and spreading with a matte or rough whitish-yellow surface, unlike the convex colonies of other Candida species.
Fig. Pichia kudriavzevii ATCC strain
CHROMagar: Appears as distinctive, large, fuzzy pink colonies.
Fig. Pichia kudriavzevii growth on HiCrome Candida Differential AgarFig. Pichia kudriavzevii, Candida albicans, and Candida parasilosis growth on HiCrome Candida Differential Agar
Liquid Media: Often forms a surface pellicle (film).
Pathogenicity
Risk Factors: Primarily affects immunocompromised patients, such as those with neutropenia, hematological malignancies (leukemia), or those undergoing organ transplants.
Virulence Factors: Includes the ability to form biofilms, produce degradative enzymes (phospholipases, proteases, hemolysins), and adhere to host tissues.
Clinical Manifestations:
Fungemia: Bloodstream infections associated with high mortality rates (up to 67%).
Vaginitis: An important etiological agent in some cases of vaginal candidiasis.
Other: Fungal peritonitis, endocarditis, and mucocutaneous infections.
Lab Diagnosis
Culture: Isolation on Sabouraud Dextrose Agar (SDA) followed by observation of spreading matte colonies.
Fig. Pichia kudriavzevii colony characteristics on SDA
Biochemical Tests: Distinguished by its ability to grow on vitamin-free media (unlike most Candida species) and its specific sugar fermentation profile (ferments glucose but typically not sucrose or lactose).
Molecular Methods: Definitive identification via DNA sequencing of the ITS1-ITS2 or D1/D2 regions of rDNA.
MALDI-TOF MS: Now a standard tool for rapid species-level identification in clinical labs.
Treatment
Intrinsic Resistance: It is naturally resistant to fluconazole, a common antifungal. This is due to low affinity for the target enzyme and high expression of efflux pumps.
Recommended Agents:
Voriconazole: Often effective.
Amphotericin B: Generally effective, though it may show reduced susceptibility compared toC. albicans.
Echinocandins: Such as caspofungin, micafungin, and anidulafungin.
Prevention
Infection Control: Strict hygiene and sanitation in healthcare settings, including handwashing and disinfecting medical equipment.
Stewardship: Avoiding unnecessary prophylactic use of fluconazole, which can select for this resistant species.
Surveillance: Monitoring the incidence and susceptibility patterns in hospital environments to prevent outbreaks.
Keynotes
The “One-Name” Rule: Modern taxonomy prefers Pichia kudriavzevii over its asexual name, Candida krusei.
WHO Priority: It is listed on the World Health Organization’s Fungal Priority Pathogen List due to its drug resistance and high mortality.
Fig. Pichia kudriavzevii germ tube test
Acid Specialist: Its unique ability to degrade organic acids (like lactic acid) makes it a “yeast of choice” for coffee and cocoa fermentation.